期刊文献+

CYP17基因多态性与围绝经期综合征的关系 被引量:2

下载PDF
导出
摘要 在围绝经期,女性由于卵巢功能的逐渐衰退,体内雌激素的下降,可以出现一系列近期及远期症状如潮热、盗汗、抑郁、失眠、骨质疏松、心血管疾病及老年性痴呆等,这严重影响着更、老年期女性身心健康及生活质量。但并不是所有女性都出现围绝经期症状,且有症状女性的严重程度又不尽相同。因此推测,围绝经期综合征的这种多样性表现可能与某些基因多态性有关联。
出处 《中国药物与临床》 CAS 2016年第5期679-681,共3页 Chinese Remedies & Clinics
基金 山西省卫生厅科技攻关项目(200918)
  • 相关文献

参考文献9

  • 1Stuenkel CA,Davis SR,Gompel A,et al.Treatment of symptoms of the menopause:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2015,100(11):3975-4011.
  • 2Haiman CA,Hankinson SE,Spiegelman D,et al.The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer[J].Cancer Res,1999,59(5):1015-1020.
  • 3曹泽毅.中华妇产科学(下册)[M].2版.北京:人民卫生出版社,2005:2537.
  • 4Alleyne AT,Austin S,Williams A.Distribution of CYP17αpolymorphism and selected physiochemical factors of uterine leiomyoma in Barbados[J].Meta Gene,2014,9(2):358-365.
  • 5Gold EB,Crawford SL,Avis NE,et al.Factors related to age at natural menopause:longitudinal analyses from SWAN[J].Am J Epidemiol,2013,178(1):70-83.
  • 6Sharp L,Cardy AH,Cotton SC,et al.CYP17 gene polymorphisms:prevalence and associations with hormone levels and associated factors:a HUGE review[J].Am J Epidemiol,2004,160(8):729-740.
  • 7Francis Y,Hwei-Ming P,Haoming Z,et al.Epoxiation activities of human cytochromes P450c17 and P450c21[J].Biochemistry,2014,53(48):7531-7540.
  • 8谭文,齐军,邢德印,缪小平,潘凯枫,张联,林东昕.雌激素代谢基因COMT和CYP17单核苷酸多态与女性乳腺癌风险的关系[J].中华肿瘤杂志,2003,25(5):453-456. 被引量:15
  • 9Zmuda JM,Cauley JA,Kuller LH,et al.A common promotor variant in the cytochrome P450c17alpha(CYP17)gene is associated with bioavailability testosterone levels and bone size in men[J].J Bone Miner Res,2001,16(5):911-917.

二级参考文献18

  • 1Bergman-Jungestrom M, Wingren S, Catechol-O-methyltransfrase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer, 2001. 85:859-862.
  • 2Yue TL, Wang X, Louden CS, et al. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and fas expression. Mol Pharmacol, 1997, 51:951-962.
  • 3Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis, 1998, 19:1-27.
  • 4Dunning AM, Healey CS, Pharoah PD, et al. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer, 1998, 77:2045-2047.
  • 5Mitrunen K, Jourenkova N, Kataja V, et al. Steroid metabolism gene CYP17 polymolphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev, 2000, 9:1343-1348.
  • 6Dunning AM, Healey CS, Pharoah PD, et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkeas Prey, 1999, 8:843-854.
  • 7Lachman HM, Papolos DF, Saito T, et al. Human catechol-O-methytransferase pharmacogenetics: description of functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996. 6:243-250.
  • 8Carey AH, Waterworth D, Patel K, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP 17. Hum Mol Genet, 1994, 3:1873-1876.
  • 9Thompson PA, Shields PG, Freudenheim JL, et al. Genetic polymolphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res, 1998, 58:2107-2110.
  • 10Feigelson HS, Coetzee CA, Kolonel LN, et al. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res, 1997, 57:1063-1065.

共引文献14

同被引文献26

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部